MobiHealth News April 7, 2025
The funding round brings the company’s total raise to $1.86 billion since it launched in 2018.
Biotechnology and precision medicine company Caris Life Sciences announced it raised $168 million in growth capital funding.
Caris Life Sciences has now raised $1.86 billion in capital since 2018.
Braidwell LP led the round with participation from new investors Perceptive Advisors, Woodline and Ghisallo.
Millennium Management and First Light Asset Management also participated in the round.
WHAT IT DOES
Caris is involved in pathology and molecular profiling to diagnose and treat cancerous tissues.
It uses molecular science AI and machine learning algorithms to analyze cancer to help guide physicians in making treatment decisions.
The company will use the money to grow...
Today's Sponsors
Today's Sponsor